Joel Beatty Analyst Performance

Biotechnology Equity Research Analyst at Robert W. Baird

Joel Beatty is a stock analyst at Robert W. Baird, covering 40 publicly traded companies across a range of sectors. Over the past year, Joel Beatty has issued 28 stock ratings, including buy and hold recommendations. While full access to Joel Beatty's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Joel Beatty's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rating: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 87 Last 10 Years
Buy Recommendations: 70.73% 58 Buy Ratings
Companies Covered: 40 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	70.7%	58 ratings
Hold	28.0%	23 ratings
Sell	1.2%	1 ratings

Out of 82 total stock ratings issued by Joel Beatty at Robert W. Baird, the majority (70.7%) have been Buy recommendations, followed by 28.0% Hold and 1.2% Sell.

Best & Worst Calls

Best Call
0000.0%
TPST
May 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
TPST
Mar 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	97.5% of companies on NASDAQ	39 companies
NYSE	2.5% of companies on NYSE	1 company

Joel Beatty, an analyst at Robert W. Baird, currently covers 40 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 38 companies	95.0%
	Consumer Staples 1 company	2.5%
	Miscellaneous 1 company	2.5%

Joel Beatty of Robert W. Baird specializes in stock coverage within the Medical sector, with additional focus on Consumer Staples and companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 27 companies	67.5%
MED - DRUGS 5 companies	12.5%
PHARMACEUTICAL PREPARATIONS 3 companies	7.5%
BIOTECHNOLOGY 2 companies	5.0%
COSMETICS&TLTRS 1 company	2.5%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 1 company	2.5%
Miscellaneous 1 company	2.5%

Time Frame

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
EDIT Editas Medicine	8/13/2025	Boost Price Target	$2.29	$6.00	Outperform
PTCT PTC Therapeutics	8/8/2025	Set Price Target	$45.38	$70.00
COGT Cogent Biosciences	7/8/2025	Boost Price Target	$9.35	$9.00	Neutral
SAGE Sage Therapeutics	6/20/2025	Boost Price Target	$9.15	$9.00	Neutral
ELF e.l.f. Beauty	6/6/2025	Boost Price Target	$118.65	$145.00	Outperform
ACAD ACADIA Pharmaceuticals	5/19/2025	Boost Price Target	$21.76	$31.00	Outperform
NGNE Neurogene	5/16/2025	Downgrade	$19.37	$24.00	Neutral
ELF e.l.f. Beauty	5/14/2025	Boost Price Target	$78.35	$100.00	Outperform
EDIT Editas Medicine	5/13/2025	Lower Price Target	$1.54	$4.00	Outperform
DNTH Dianthus Therapeutics	5/13/2025	Lower Price Target	$20.08	$50.00	Outperform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ARGX argenex	5/13/2025	Upgrade	$560.90	$680.00	Outperform
DNLI Denali Therapeutics	5/8/2025	Lower Price Target	$14.26	$29.00	Outperform
PTCT PTC Therapeutics	5/7/2025	Lower Price Target	$40.26	$66.00	Outperform
JAZZ Jazz Pharmaceuticals	5/7/2025	Lower Price Target	$102.22	$155.00	Outperform
COGT Cogent Biosciences	5/7/2025	Lower Price Target	$4.74	$7.00	Neutral
AXSM Axsome Therapeutics	5/6/2025	Boost Price Target	$116.49	$162.00	Outperform
ALKS Alkermes	5/2/2025	Boost Price Target	$30.58	$41.00	Outperform
NGNE Neurogene	3/25/2025	Set Price Target	$8.20	$38.00
LRMR Larimar Therapeutics	3/25/2025	Lower Price Target	$2.28	$10.00	Outperform
CTNM Contineum Therapeutics	3/7/2025	Lower Price Target	$6.44	$16.00	Outperform
MNMD Mind Medicine (MindMed)	3/7/2025	Lower Price Target	$6.61	$16.00	Outperform
ARGX argenex	3/4/2025	Boost Price Target	$631.50	$680.00	Neutral
PRAX Praxis Precision Medicines	3/3/2025	Lower Price Target	$38.60	$73.00	Outperform
CPRX Catalyst Pharmaceuticals	3/3/2025	Boost Price Target	$22.89	$32.00	Outperform
AXSM Axsome Therapeutics	3/3/2025	Boost Price Target	$127.54	$160.00	Outperform
COGT Cogent Biosciences	2/27/2025	Lower Price Target	$6.71	$8.00	Neutral
CPRX Catalyst Pharmaceuticals	2/4/2025	Initiated Coverage	$22.62	$28.00	Outperform
AXSM Axsome Therapeutics	2/3/2025	Set Price Target	$137.75	$132.00

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.